See more : Delhi Bank Corp. (DWNX) Income Statement Analysis – Financial Results
Complete financial analysis of TAKE Solutions Limited (TAKE.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of TAKE Solutions Limited, a leading company in the Biotechnology industry within the Healthcare sector.
- Bondada Engineering Limited (BONDADA.BO) Income Statement Analysis – Financial Results
- Nordea Invest – Korte obligationer Lagerbeskattet (NDIKOLKL1.CO) Income Statement Analysis – Financial Results
- Jiujiang Shanshui Technology Co.,Ltd (301190.SZ) Income Statement Analysis – Financial Results
- Axcella Health Inc. (AXLA) Income Statement Analysis – Financial Results
- Matinas BioPharma Holdings, Inc. (MTNB) Income Statement Analysis – Financial Results
TAKE Solutions Limited (TAKE.NS)
About TAKE Solutions Limited
TAKE Solutions Limited, together with its subsidiaries, provides domain-intensive services and solutions in life sciences and supply chain management in the United States, the Asia Pacific, and Europe. The company offers IP-driven and technology backed solutions, consulting, and functional services across clinical, regulatory, and safety for life sciences industry. It also provides clinical research, generics development, data sciences, regulatory affairs, and pharmacovigilance/safety services. In addition, the company provides IT infrastructure and support, supply chain management, engineering, designing, and sourcing services. It serves to large and small innovator biopharmaceutical and devices companies, as well as generics manufacturers. The company was incorporated in 2000 and is headquartered in Chennai, India. TAKE Solutions Limited is a subsidiary of TAKE Solutions Pte. Limited.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 656.08M | 1.89B | 6.55B | 7.74B | 22.13B | 20.39B | 15.87B | 13.45B | 10.30B | 7.30B | 8.16B | 8.32B | 7.04B | 5.00B | 3.52B | 3.35B | 2.94B | 1.82B |
Cost of Revenue | 472.66M | 830.11M | 1.94B | 1.88B | 6.62B | 5.74B | 4.57B | 7.78B | 5.75B | 4.09B | 2.54B | 2.65B | 2.45B | 3.07B | 2.35B | 2.15B | 1.89B | 1.18B |
Gross Profit | 183.42M | 1.06B | 4.61B | 5.86B | 15.51B | 14.65B | 11.31B | 5.66B | 4.55B | 3.21B | 5.62B | 5.67B | 4.59B | 1.93B | 1.16B | 1.21B | 1.05B | 643.48M |
Gross Profit Ratio | 27.96% | 56.10% | 70.38% | 75.70% | 70.10% | 71.85% | 71.23% | 42.11% | 44.16% | 43.97% | 68.92% | 68.21% | 65.21% | 38.64% | 33.07% | 36.05% | 35.59% | 35.32% |
Research & Development | 80.00K | 80.00K | 70.67M | 130.63M | 67.19M | 0.00 | 0.00 | 0.00 | 0.00 | 392.80M | 396.18M | 241.05M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 396.23M | 99.77M | 771.58M | 698.39M | 2.24B | 1.46B | 1.07B | 634.18M | 480.79M | 149.57M | 496.17M | 457.94M | 575.81M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 680.00K | 3.09M | 24.11M | 58.65M | 702.80M | 672.97M | 615.25M | 499.13M | 875.44M | 386.63M | 720.10M | 711.96M | 510.35M | 116.37M | 55.50M | 63.44M | 58.85M | 35.92M |
SG&A | 396.91M | 102.86M | 795.69M | 757.04M | 2.94B | 2.13B | 1.69B | 1.13B | 1.36B | 536.20M | 1.69B | 1.59B | 1.09B | 116.37M | 55.50M | 63.44M | 58.85M | 35.92M |
Other Expenses | 0.00 | 84.47M | 93.18M | 104.37M | 5.75M | 4.17M | 11.55M | 14.17M | 5.67M | 11.83M | 6.84M | 5.50M | 5.25M | -26.44M | 46.21M | -2.08M | -4.62M | -5.37M |
Operating Expenses | 396.91M | 1.42B | 5.26B | 7.36B | 15.34B | 12.33B | 9.27B | 3.97B | 3.15B | 2.31B | 4.92B | 4.52B | 3.37B | 862.23M | 584.03M | 458.65M | 270.33M | 181.39M |
Cost & Expenses | 863.02M | 2.25B | 7.20B | 9.24B | 21.95B | 18.07B | 13.84B | 11.75B | 8.91B | 6.41B | 7.45B | 7.17B | 5.82B | 3.93B | 2.94B | 2.60B | 2.16B | 1.36B |
Interest Income | 0.00 | 8.30M | 7.30M | 9.01M | 14.27M | 48.01M | 27.76M | 57.86M | 15.68M | 49.72M | 50.32M | 49.60M | 47.44M | 46.97M | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 54.31M | 74.54M | 270.98M | 294.63M | 322.02M | 173.42M | 128.70M | 126.03M | 60.04M | 64.54M | 137.69M | 143.83M | 182.82M | 77.42M | 39.00M | 17.80M | 69.29M | 34.19M |
Depreciation & Amortization | 78.75M | 168.40M | 756.25M | 1.15B | 1.67B | 1.54B | 1.04B | 874.49M | 247.86M | 203.27M | 372.66M | 222.70M | 78.74M | 47.24M | 42.77M | 33.98M | 22.22M | 10.23M |
EBITDA | -1.05B | -209.79M | 269.00M | -2.86B | 1.95B | 3.95B | 3.13B | 2.75B | 1.62B | 1.08B | 964.80M | 1.61B | 1.45B | 1.09B | 714.57M | 809.88M | 874.58M | 472.33M |
EBITDA Ratio | -160.17% | -5.60% | 6.93% | -4.80% | 8.92% | 18.93% | 19.12% | 18.83% | 20.07% | 20.49% | 18.76% | 19.40% | 21.90% | 25.74% | 22.84% | 27.44% | 29.76% | 28.21% |
Operating Income | -213.49M | -357.29M | -655.23M | -1.82B | 20.02M | 2.32B | 2.03B | 1.69B | 1.39B | 898.12M | 703.75M | 1.15B | 1.22B | 1.07B | 579.39M | 750.65M | 775.75M | 462.10M |
Operating Income Ratio | -32.54% | -18.90% | -10.00% | -23.54% | 0.09% | 11.35% | 12.81% | 12.60% | 13.54% | 12.30% | 8.63% | 13.83% | 17.36% | 21.41% | 16.47% | 22.38% | 26.39% | 25.37% |
Total Other Income/Expenses | -970.41M | -95.44M | -178.97M | -2.89B | -305.23M | -158.36M | -153.30M | -120.20M | 54.81M | -48.28M | -76.18M | -77.39M | -68.72M | -270.64M | -174.06M | -180.90M | -150.51M | -81.12M |
Income Before Tax | -1.18B | -452.73M | -853.07M | -4.39B | -129.17M | 2.16B | 1.88B | 1.53B | 1.45B | 853.73M | 627.57M | 1.07B | 1.15B | 800.47M | 405.32M | 595.00M | 625.24M | 380.97M |
Income Before Tax Ratio | -180.45% | -23.95% | -13.02% | -56.69% | -0.58% | 10.58% | 11.84% | 11.38% | 14.07% | 11.69% | 7.70% | 12.90% | 16.38% | 16.00% | 11.52% | 17.74% | 21.27% | 20.91% |
Income Tax Expense | 12.30M | 16.80M | 36.16M | 135.51M | -19.75M | 372.97M | 281.17M | 191.56M | 200.84M | 54.42M | 9.98M | 181.88M | 211.28M | 64.95M | 42.46M | 55.01M | 85.88M | 50.56M |
Net Income | -1.20B | -1.00B | -7.82B | -4.52B | -123.60M | 1.77B | 1.60B | 1.31B | 1.20B | 698.83M | 580.00M | 794.70M | 941.59M | 735.52M | 362.86M | 539.99M | 539.36M | 330.42M |
Net Income Ratio | -182.33% | -53.03% | -119.39% | -58.40% | -0.56% | 8.70% | 10.11% | 9.72% | 11.62% | 9.57% | 7.11% | 9.55% | 13.38% | 14.70% | 10.32% | 16.10% | 18.35% | 18.14% |
EPS | -8.18 | -6.86 | -53.50 | -30.91 | -0.85 | 12.13 | 12.19 | 11.22 | 9.97 | 5.82 | 4.83 | 6.62 | 7.13 | 5.83 | 2.70 | 4.44 | 4.74 | 3.50 |
EPS Diluted | -8.18 | -6.86 | -53.50 | -30.91 | -0.85 | 12.09 | 12.15 | 11.19 | 9.85 | 5.82 | 4.83 | 6.61 | 7.11 | 5.82 | 2.70 | 4.44 | 4.74 | 3.50 |
Weighted Avg Shares Out | 146.23M | 146.22M | 146.22M | 146.22M | 146.22M | 146.14M | 131.59M | 127.50M | 120.05M | 120.00M | 120.00M | 120.00M | 120.00M | 120.00M | 120.00M | 120.00M | 110.93M | 90.31M |
Weighted Avg Shares Out (Dil) | 146.23M | 146.22M | 146.22M | 146.22M | 146.22M | 146.59M | 132.02M | 127.90M | 121.50M | 120.14M | 120.21M | 120.22M | 120.30M | 120.31M | 120.00M | 120.00M | 110.93M | 90.31M |
Source: https://incomestatements.info
Category: Stock Reports